
Our medical experts are ready to answer your questions and guide you through your treatment options.
Understanding the PGT-A/PGT-M (Genetic Testing of Embryos) success rate in Bengaluru is crucial for informed family planning decisions. This advanced reproductive technology’s outcome is influenced by numerous factors, including patient-specific conditions, the specific type of PGT performed, and the quality of the embryology laboratory. Bengaluru stands as a prominent destination for fertility treatments, offering a detailed perspective on these intricate outcomes.
Success rates for PGT-A/PGT-M in Bengaluru are meticulously reviewed through aggregated clinical data from leading fertility centers. These insights allow for a comprehensive evaluation of treatment efficacy, considering varying methodologies and patient demographics. Outcome trends here are often benchmarked against national and international standards, reflecting the city’s commitment to evidence-based reproductive healthcare.
For PGT-A/PGT-M (Genetic Testing of Embryos), "success" typically refers to the identification of a euploid (chromosomally normal) or unaffected embryo suitable for transfer, leading to a successful implantation, clinical pregnancy, and ultimately, a live birth. It also encompasses the rate of identifying viable embryos after testing. Distinguishing between these short-term and long-term outcomes is vital for patients researching their options and understanding the full journey.
Success rates vary depending on treatment approach and patient factors.
| Treatment Type / Category | Typical Use Case | Success Rate Range (%) | What Success Indicates |
|---|---|---|---|
| PGT-A (Aneuploidy) | Recurrent miscarriage, advanced maternal age, IVF failure | 50%–70% | Identification of euploid embryo for transfer; live birth rate |
| PGT-M (Monogenic Disorders) | Known genetic disease in family (e.g., cystic fibrosis, Huntington's) | 45%–65% | Identification of unaffected embryo for transfer; live birth rate |
| PGT-SR (Structural Rearrangements) | Parent has chromosomal translocation or inversion | 40%–60% | Identification of balanced/normal embryo for transfer; live birth rate |
| Overall PGT Cycle with Transfer | Successful embryo biopsy, testing, and transfer leading to pregnancy | 35%–55% | Achieving a clinical pregnancy; live birth |
The PGT-A/PGT-M (Genetic Testing of Embryos) survival rate by age in Bengaluru, particularly maternal age, significantly impacts outcomes. Younger individuals generally exhibit a higher yield of euploid embryos and subsequent live birth rates. Furthermore, the stage wise PGT-A/PGT-M (Genetic Testing of Embryos) survival rate in Bengaluru, particularly for blastocyst biopsies, aligns with international clinical trends in reproductive medicine.
| Age Group / Patient Category | Primary Impact on Outcome | Success Rate Range (%) |
|---|---|---|
| Under 35 years | Higher euploid embryo yield | 60%–75% |
| 35–39 years | Moderate euploid embryo yield | 45%–60% |
| 40–42 years | Lower euploid embryo yield | 25%–40% |
| Over 42 years | Significantly reduced euploid embryo yield | 10%–25% |
| Embryo Development Stage (Blastocyst) | Successful biopsy and genetic analysis | 90%–98% (for genetic analysis success) |
The PGT-A/PGT-M (Genetic Testing of Embryos) success rate in Bengaluru is often comparable with international standards when similar clinical protocols, advanced technology, and patient selection criteria are applied. Fertility centers here often follow global best practices, ensuring competitive outcomes for patients seeking these specialized services. This parity helps bolster confidence in the local healthcare infrastructure.
| Country | PGT-A/PGT-M Success Rate Range (%) (Live Birth) |
|---|---|
| India (Bengaluru) | 35%–55% |
| United States | 40%–60% |
| United Kingdom | 38%–58% |
| Canada | 37%–56% |
| Australia | 39%–59% |
| Germany | 36%–55% |
| Spain | 38%–57% |
These rates are indicative and can vary significantly based on individual patient health, specific treatment methodologies, and unique genetic factors. Success is never guaranteed due to the biological complexities involved.
Navigating PGT-A/PGT-M outcomes requires understanding nuanced data. Patients are encouraged to discuss their individual profiles with specialists to make confident and well-informed healthcare decisions for their journey.
India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.
Meet our team of highly qualified and experienced medical professionals dedicated to providing the best healthcare services.
Get Personalized Medical Treatment Options From India's Top Hospitals. Our Medical Experts Are Ready To Assist You Every Step Of The Way.